About
Corolabs develops a combination of inhaled medications together with a novel delivery system capable of reaching the deep lung.
The company’s aerosol technology is used to produce and deliver sub-micron droplets to the alveoli of the lung, enabling localized treatment of lower respiratory diseases as well as systemic drug delivery. This novel technology allows home-based treatments of lower respiratory diseases, traditionally treated only in hospital settings by intramuscular injection or intravenous therapy.
Additional advantages of targeted drug delivery to the deep lung include potential rapid onset of action as well as the opportunity for dose sparing and reduced side effects of systemically available drugs.
Corolabs was established shortly after the onset of the COVID-19 outbreak in Israel, after it became evident that COVID-19 mortality occurs as a result of deep-lung infections triggered by the coronavirus.
Corolabs is a subsidiary of Omega Life Science.
Q&A
- What is Corolabs' current operational status?
- Corolabs is currently inactive, having ceased operations in December 2024.
- What is Corolabs' primary focus?
- Corolabs focuses on deep-lung inhalation therapies for infectious diseases, developing inhaled medications with a novel delivery system for sub-micron droplets to the alveoli.
- When was Corolabs founded?
- Corolabs was established in April 2020, shortly after the onset of the COVID-19 outbreak in Israel.
- Who is the CEO and Co-founder of Corolabs?
- Asaf Weinberger is the Co-founder and CEO of Corolabs.
- What is Corolabs' current product stage?
- Corolabs' product is in the clinical trial stage.
- What is Corolabs' primary sector?
- Corolabs' primary sector is Health Tech & Life Sciences.
- Is Corolabs a subsidiary of another company?
- Yes, Corolabs is a subsidiary of Omega Life Science.
Team · 1
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Former names | Pulmogen |
|---|---|
| Founded | 2020-4 |
| Employees (exact) | 6 |
| Status reason | Non Active, Dec 2024 ceased to operate |